# HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

> **NCT01718301** · PHASE3 · TERMINATED · sponsor: **Anna Cruceta** · enrollment: 108 (actual)

## Conditions studied

- Hepatitis C
- HIV Infections
- COINFECTION

## Interventions

- **DRUG:** boceprevir
- **DRUG:** Ribavirin
- **DRUG:** Peginterferon alfa-2a
- **DRUG:** Peginterferon alfa-2b

## Key facts

- **NCT ID:** NCT01718301
- **Lead sponsor:** Anna Cruceta
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03-10
- **Primary completion:** 2015-03-20
- **Final completion:** 2015-06-30
- **Target enrollment:** 108 (ACTUAL)
- **Why stopped:** Difficulty in patient recruitment
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718301, "HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01718301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*